Crossmark

Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy

Crossref DOI link: https://doi.org/10.1186/s13045-018-0624-2

Published Online: 2018-06-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rossari, Federico

Minutolo, Filippo

Orciuolo, Enrico
License Information

Text and Data Mining valid from 2018-06-20
More Information

Article History

Received: 14 March 2018

Accepted: 1 June 2018

First Online: 20 June 2018

Ethics approval and consent to participate

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.